Orbis Allan Gray LTD Alnylam Pharmaceuticals, Inc. Transaction History
Orbis Allan Gray LTD
- $15.5 Billion
- Q3 2024
A detailed history of Orbis Allan Gray LTD transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Orbis Allan Gray LTD holds 1,268,112 shares of ALNY stock, worth $321 Million. This represents 2.25% of its overall portfolio holdings.
Number of Shares
1,268,112
Previous 721,053
75.87%
Holding current value
$321 Million
Previous $175 Million
99.09%
% of portfolio
2.25%
Previous 1.2%
Shares
3 transactions
Others Institutions Holding ALNY
# of Institutions
644Shares Held
109MCall Options Held
1.28MPut Options Held
1.21M-
Capital World Investors Los Angeles, CA16.5MShares$4.18 Billion0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.6MShares$3.2 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.42 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.24MShares$1.33 Billion0.31% of portfolio
-
Wellington Management Group LLP Boston, MA4.95MShares$1.25 Billion0.24% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $31.1B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...